Clinical Trial Update: A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated converting liver transplant recipients from immediate-release tacrolimus (Prograf) to extended-release tacrolimus (Advagraf); the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: de Novo Liver Transplant Subjects | Phase 4 | Status: COMPLETED